Partnering is at the heart of Nycomed’s growth strategy. We expect most of our future products to originate outside the company.
Therefore, we have integrated the art of partnering into our organisational roots. Our financial strength, global presence and R&D skills make Nycomed an attractive partner for companies delivering tomorrow’s breakthrough products.
As a company, we are collaborative, proactive, flexible and ambitious, and driven by a common goal to bring new medicines to patients that improve their lives. Our decision processes are lean and flexible, and we have the resources to invest in promising projects